Investigation to Understand and Optimize Psilocybin
Status:
RECRUITING
Trial end date:
2029-05-01
Target enrollment:
Participant gender:
Summary
This study will examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression. It will also assess whether different post-dosing interventions, including a non-invasive technique called transcutaneous auricular Vagus Nerve Stimulation (taVNS), influence various psychological and behavioral outcomes. In addition, the study will explore objective measures of real-world social behavior and identify early behavioral responses that may be associated with long-term treatment outcomes.
Phase:
PHASE2
Details
Lead Sponsor:
Charles Raison
Collaborators:
Emory University Steadman Philippon Research Institute Tiny Blue Dot Foundation Usona Institute